完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.author | Yang Jinn-Moon | en_US |
| dc.contributor.author | Hsu Kai-Cheng | en_US |
| dc.date.accessioned | 2014-12-16T06:14:47Z | - |
| dc.date.available | 2014-12-16T06:14:47Z | - |
| dc.date.issued | 2014-07-10 | en_US |
| dc.identifier.govdoc | G01N033/573 | zh_TW |
| dc.identifier.govdoc | A61K031/255 | zh_TW |
| dc.identifier.govdoc | A61K031/196 | zh_TW |
| dc.identifier.govdoc | A61K031/662 | zh_TW |
| dc.identifier.govdoc | A61K031/185 | zh_TW |
| dc.identifier.uri | http://hdl.handle.net/11536/104890 | - |
| dc.description.abstract | A drug screening method is disclosed. The drug screening method includes steps of screening a compound library to obtain a first group of compounds capable of binding to a wild type target; screening the first group of compounds to obtain a second group of compounds capable of binding to a mutant site of a mutant target; analyzing characteristics of binding sites of the wild type target and the mutant type target to obtain physico-chemical properties of the binding sites; identifying a candidate from the second group of compounds according to the physico-chemical properties of the binding site; and performing a bio-assay on inhibitory activity of the candidate. | zh_TW |
| dc.language.iso | zh_TW | en_US |
| dc.title | DRUG SCREENING METHOD | zh_TW |
| dc.type | Patents | en_US |
| dc.citation.patentcountry | USA | zh_TW |
| dc.citation.patentnumber | 20140194392 | zh_TW |
| 顯示於類別: | 專利資料 | |

